Buprenorphine Market Is Estimated To Witness High Growth Owing To Increasing Approval Of New Products

Buprenorphine Market


 Market Overview:

The buprenorphine market includes drugs used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps reducing withdrawal symptoms in patients suffering from opioid dependency. It provides an effective treatment option due to its high affinity for opioid receptors and relatively low intrinsic efficacy.

Market key trends:
One of the major trends in The Buprenorphine Market Demand is increasing approval of new products. In April 2023, Braeburn received FDA approval for weekly buprenorphine depot injection (CAM2038) for the treatment of moderate to severe opioid use disorder. The drug delivers continuous plasma levels of buprenorphine over a week with a single subcutaneous injection. Such new product approvals are expected to fuel the market growth during the forecast period by providing improved treatment options.

Porter’s Analysis
Threat of new entrants: Low barrier for new players to enter the market due to moderate capital requirements. However, established brands, patents and economies of scale advantage enjoyed by existing players pose entry barriers.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and differentiated products offered by suppliers.
Bargaining power of suppliers: Suppliers have low-to-moderate bargaining power due to availability of substitute raw materials and inputs. However, compliance with stringent regulations provides some bargaining power.
Threat of new substitutes: Threat of substitutes is moderate as alternative drug therapies are available.
Competitive rivalry: Intense competition due to large number of branded and generic manufacturers.

SWOT Analysis
Strength: wide applications in treating opioid dependence and chronic pain. growing awareness and demand.
Weakness: strict regulations for production and distribution. risk of abuse and addiction.
Opportunity: growing geriatric population prone to chronic diseases. scope in emerging markets.
Threats: entry of alternative drug therapies. pricing pressure due to low-cost generic competitors.

Key Takeaways
The global buprenorphine market is expected to witness high growth at a CAGR of 14% over the forecast period, due to increasing prevalence of opioid use disorders and chronic pain conditions.
Regionally, North America dominated the global market and is expected to maintain its lead, owing to rising healthcare spending and growing adoption of buprenorphine therapy. Asia Pacific is anticipated to exhibit fastest growth owing to rising geriatric population, growing awareness and improving healthcare infrastructure in major countries like India and China.
Key players operating in the buprenorphine market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co. Major players are focusing on expanding their manufacturing facilities and product portfolios through acquisitions and collaborations to strengthen their market position.

Read More:

https://www.dailyprbulletin.com/rising-addiction-rates-to-drive-the-growth-of-buprenorphine-market/

Comments

Post a Comment

Popular posts from this blog

Precast Concrete Market Is Estimated To Witness High Growth Owing To Increasing Demand for Sustainable Construction Practices

Image
Precast Concrete Market Market Overview: The Precast Concrete Market is witnessing significant growth due to the increasing demand for sustainable construction practices. Precast concrete products are prefabricated in controlled factory conditions, offering several advantages such as improved quality control, reduced construction time, and increased durability. These products are widely used in residential, commercial, and infrastructure projects due to their ability to enhance construction efficiency and productivity. With the growing need for energy-efficient and environmentally friendly buildings, the demand for precast concrete products is expected to rise. Market Key Trends: One key trend in the Precast Concrete Market is the adoption of advanced technology in manufacturing processes. The use of computer-aided design (CAD) and building information modeling (BIM) is enabling manufacturers to produce complex and customized precast concrete products with high precision. Additional
Read more

Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Growth driven by increased adoption of targeted therapies

Image
Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Market Overview: Relapsed Or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL) is an aggressive fast-growing type of non-Hodgkin's lymphoma (NHL) cancer that generally affects immune system cells called B cells. DLBCL can occur at any age but is most common in older adults. Novel targeted therapies like chimeric antigen receptor (CAR) T-cell therapies, bispecific antibodies and antibody-drug conjugates are revolutionizing the treatment of R/R DLBCL. These advanced therapies are offering new hope to patients by increasing survival rates. Market key trends: One of the key trends in the R/R DLBCL market is the increasing adoption of CAR T-cell therapies. CAR T-cell therapy is an innovative new approach to treating R/R DLBCL through the use of genetically engineered T-cells. Drugs like Kymriah and Yescarta have proven highly effective in treating certain patients with relapsed or refractory forms of large B-cell lymphoma.
Read more

The global Biopharmaceuticals Market connected with therapeutic biologics

Image
Biopharmaceuticals Market Market Overview: The biopharmaceuticals market comprises medicines produced using biotechnology methods like genetic engineering and includes vaccines, blood components, recombinant therapeutic proteins/antibodies, and monoclonal antibodies. Biopharmaceuticals are often used for treating serious medical conditions like cancer, autoimmune diseases, and other chronic disorders. These drugs provide targeted treatment options and have lesser side effects than traditional small-molecule drugs. The market is witnessing high demand due to increasing prevalence of chronic diseases and growing geriatric population globally. Market key trends: One of the key trends gaining traction in The Biopharmaceuticals Market Demand is the increasing adoption of biosimilars. Biosimilars are quasi-generic versions of original biologics and provide more affordable treatment options when the patents of biologics expire. Regulatory agencies in various regions are also approving bios
Read more